WebGLASSIA is a medicine containing human Alpha 1-Proteinase Inhibitor (Alpha 1-PI) that is used to treat adults with lung disease (emphysema) because of severe Alpha 1 … Web20 okt. 2005 · Brief Summary: The primary purpose of this study is to characterize the pharmacokinetic profile of intravenous Aralast Fraction (Fr.) IV-1, a sterile, stable, lyophilized preparation of functionally intact human Alpha1- Proteinase Inhibitor (α1-PI). This pharmacokinetic study will be a randomized controlled clinical trial with a cross-over design.
Aralast (Baxter Healthcare), Drug Reference Encyclopedia
WebPlease call IngenioRx at 1-833-255-0646 to request a needed medication. Brand name Generic drug name 8-MOP METHOXSALEN ABRAXANE PACLITAXEL PROTEIN-BOUND ACTEMRA TOCILIZUMAB ... ARALAST NP ALPHA-1-PROTEINASE INHIBITOR ARANESP DARBEPOETIN ALFA IN POLYSORBAT . Anthem Blue Cross and Blue … WebThere are four augmentation therapy products approved by the U.S. Food and Drug Administration (FDA) and available in the United States, and more potential therapies are on the horizon. The five approved products are Prolastin-C® and Prolastin-C Liquid® from Grifols, Aralast NP™ from Takeda, Zemaira® from CSL Behring and Glassia® from … cz 457 action only
Aralast Advanced Patient Information - Drugs.com
Web17 aug. 2010 · The drug Alpha-1 Antitrypsin (AAT, Aralast NP) is being tested in this study as an anti-inflammatory drug (a medication that decreases inflammation, which is part of the body's normal ability to fight infection and respond to injuries) that affects the cells thought to be involved in the development of type 1 diabetes mellitus (T1DM, T1D). WebAlpha-1 antitrypsin or α 1-antitrypsin (A1AT, α 1 AT, A1A, or AAT) is a protein belonging to the serpin superfamily. It is encoded in humans by the SERPINA1 gene.A protease inhibitor, it is also known as alpha 1 … Web21 mrt. 2024 · The crossover trial was a multicenter, randomized, double-blind, single-dose pharmacokinetic (PK) comparability trial conducted in 25 subjects with severe congenital Alpha 1-PI deficiency to evaluate the pharmacokinetics of ARALAST NP (test drug, 60 mg/kg body weight) as compared to ARALAST (reference drug, 60 mg/kg body weight), … bingham custom meats